iPSCs诱导的造血干细胞对内皮细胞血管生成作用的影响及相关作用机制研究

doi:10.3877/cma.j.issn.2095-1221.2021.04.001

目的

体外实验探讨诱导多能干细胞（iPSCs）诱导的造血干细胞（HSCs）对内皮细胞血管生成作用的影响，及其相关的作用机制。

方法

将iPSCs经体外诱导分化，形成造血干细胞（iPS-HSCs）。实验分为两组，分别为单纯人脐静脉内皮细胞（HUVECs）组和iPS-HSC+ HUVEC组（iPS-HSCs与HUVEC进行共培养）。在基质胶中观察iPS-HSCs对内皮细胞血管生成作用的影响，并采用Western blot检测血管内皮生长因子（VEGF）及血管生成素1 （Ang-1）蛋白的相对表达水平。两组间比较采用t检验。

结果

iPS-HSCs与HUVECs共培养后可促进内皮细胞的管腔形成，并提高VEGF和Ang-1的蛋白表达水平。与单纯HUVEC组相比，iPS-HSC+HUVEC组网络结点数量（10.33±1.53比28.67±3.51）升高，差异具有统计学意义（t = 8.292，P < 0.01）；iPS-HSC+HUVEC组VEGF的相对表达水平（0.86±0.09比1.44±0.11）升高，差异具有统计学意义（t = 43.715，P < 0.01）；iPS-HSC+HUVEC组Ang-1的相对表达水平（0.46±0.01比0.68±0.05）升高，差异具有统计学意义（t = 52.255，P < 0.01）。

结论

iPS细胞诱导的HSC能够促进内皮细胞的血管生成作用，其促进血管生成的作用可能与VEGF及Ang-1蛋白上调有关。

关键词: 诱导多能干细胞, 造血干细胞, 血管生成, 作用机制

Objective

To investigate the effects and the mechanism of induced pluripotent stem cells (iPSCs) induced hematopoietic stem cells on endothelial cell angiogenesis in vitro experiments.

Methods

iPS cells were induced to differentiate into hematopoietic stem cells (iPS-HSCs) in vitro. The experiment was divided into two groups: human umbilical vein endothelial cells (HUVECs) group and iPS-HSC+HUVEC group. The effects of iPS-HSCs on the angiogenesis of endothelial cells were observed in the Matrigel, and the relative expression levels of vascular endothelial growth factor (VEGF) and angiopoietin 1 (Ang-1) protein were detected by Western blot.

Results

The co-culture of iPS-HSCs and HUVECs could significantly promote the tube formation of endothelial cells, and the protein expression levels of VEGF and Ang-1 were significantly increased. Compared with HUVEC group, the number of branch points in iPS-HSC+HUVEC group (10.33±1.53 vs 28.67±3.51) was significantly increased (t = 8.292, P < 0.01) ; the relative expression level of VEGF in iPS-HSC+HUVEC group (0.86±0.09 vs 1.44±0.11) was significantly increased (t = 43.715, P < 0.01) ; the relative expression level of Ang-1 in iPS-HSC+HUVEC group (0.46±0.01 vs 0.68±0.05) was significantly higher (t =52.255, P < 0.01) .

Conclusion

The hematopoietic stem cells induced by iPS cells can promote the angiogenesis of endothelial cells, which may be related to the up-regulation of VEGF and Ang-1 proteins.

Key words: Induced pluripotent stem cells, Hematopoietic stem cells, Angiogenesis, Mechanism

表1 相关基因引物序列

基因	（5'→3'）	预期扩增产物长度（bp）
Oct3/4	上游GATCCTCGGACCTGGCTAA	592
	下游ACGAGGGTTTCTGCTTTGC	592
Sox2	上游ACAGTTACGCGCACATGAA	424
	下游GGTAGTGCTGGGACATGTGA	424
Lin28	上游GGGTCTGGAATCCATCCGTG	302
	下游GGGTAGGGCTGTGGATTTCT	302

表1 相关基因引物序列

基因	（5'→3'）	预期扩增产物长度（bp）
Oct3/4	上游GATCCTCGGACCTGGCTAA	592
	下游ACGAGGGTTTCTGCTTTGC	592
Sox2	上游ACAGTTACGCGCACATGAA	424
	下游GGTAGTGCTGGGACATGTGA	424
Lin28	上游GGGTCTGGAATCCATCCGTG	302
	下游GGGTAGGGCTGTGGATTTCT	302

图2 倒置显微镜下观察iPSCs克隆（×40）。2a为iPSCs传代形成的1号ESCs样克隆，2b为2号ESCs样克隆

图3 倒置显微镜下观察iPSCs碱性磷酸酶染色结果（×40）

图4 iPSC RT-PCR产物的电泳检测条带图

图5 倒置荧光显微镜下观察iPSCs形态（免疫荧光染色，×40）

图6 倒置显微镜下白光观察iPSCs向HSCs诱导分化的克隆形态变化（无染色，×40）

图7 iPSCs诱导分化的HSCs表型流式检测图

图8 管腔形成检测HUVEC组、iPSC-HSC+HUVEC组和iPSC-HSC+HUVEC+VEGF抗体组内皮细胞的血管生成能力

图9 Western blot检测HUVEC组和iPSC-HSC + HUVEC组内皮细胞VEGF、Ang-1蛋白的表达

1	Kondo K, Yanishi K, Hayashida R, et al. Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan[J]. Circ J, 2018, 82(4): 1168-1178.
2	Neale JPH, Pearson JT, Katare R, et al. Ghrelin, MicroRNAs, and critical limb ischemia: Hungering for a novel treatment option[J]. Front Endocrinol (Lausanne), 2017, 8: 350.
3	Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells[J]. Cell, 2009, 136: 411-419.
4	Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb[J]. Lancet, 1996, 348(9024): 370-374.
5	Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, et al. Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice[J]. PLoS One, 2012, 7(8): 43683.
6	Pavlichenko N, Sokolova I, Vijde S, et al. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats[J]. Brain Res, 2008, 1233: 203-213.
7	Neuhuber B, Timothy HB, Shumsky JS, et al. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibitdonor variations[J]. Brain Res, 2005, 1035(1): 73-85.
8	Takahashi K, S Y. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663-676.
9	Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons[J]. Science, 2008, 321(5893): 1218-1221.
10	Ebert AD, Yu J, Rose FF, Jr., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient[J]. Nature, 2009, 457(7227): 277-280.
11	Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors[J]. Cell, 2009, 136(5): 964-977.
12	Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells[J]. Science, 2008, 321(5889): 699-702.
13	Wu X, Liu N. The role of Ang/Tie signaling in lymphangiogenesis[J]. Lymphology, 2010, 43(2): 59-72.
14	Ardelt AA, Mccullough LD, Korach KS, et al. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model[J]. Stroke, 2005, 36(2): 337-341.
15	Marti HJ, Bernaudin M, Bellail A, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia[J]. Am J Pathol, 2000, 156(3): 965-976.
16	Han MK, Kim M, Bae SY, et al. VEGF protects human cerebral hybrid neurons from in vitro ischemia[J]. Neuroreport, 2004, 15(5): 847-850.
17	Shin HY, Kim JH, Phi JH, et al. Endogenous neurogenesis and neovascularization in the neocortex of the rat after focal cerebral ischemia[J]. Neuroscience Research, 2008, 86(2): 356-367.
18	Lai T, Li M, Zheng L, et al. Over-expression of VEGF in marrow stromal cells promotes angiogenesis in rats with cerebral infarction via the synergistic effects of VEGF and Ang-2[J]. J Huazhong Univ Sci Technology Med Sci, 2012, 32(5): 724-731.

[1]	刘佳璇, 何迈越, 李俏, 徐兵河. 阿帕替尼在晚期乳腺癌治疗中的临床研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(01): 1-5.
[2]	林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[3]	张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[4]	全勇, 冉新泽, 胡梦佳, 陈芳, 陈乃成, 廖伟年, 陈默, 申明强, 陈石磊, 王崧, 王军平. 低氧习服在小鼠造血干细胞急性放射损伤修复中的作用观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(04): 293-298.
[5]	张原, 李小龙, 王亚鹏. 胰腺癌中ANGPTL2蛋白与免疫抑制细胞浸润的关系及临床意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 145-148.
[6]	孔欣, 宋宝全, 刘吟, 张剑, 仇惠英, 吴德沛. 异基因造血干细胞移植并发难治性呃逆一例[J]. 中华移植杂志(电子版), 2023, 17(04): 253-255.
[7]	谭林, 蒲运刚, 朱顺, 杨希. 急性呼吸窘迫综合征患者血清FGF21、ANGPTL4、HO-1表达及其临床意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 227-229.
[8]	刘文慧, 吴涛, 张曦. 间充质干细胞联合血小板生成素受体激动剂在异基因造血干细胞移植后血小板恢复中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 242-246.
[9]	崔燕妮, 任颜, 梁凤婷, 覃艳红, 王宏伟. 脐带血源性产品Omidubicel的临床研发进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 178-182.
[10]	李芸芸, 吴涛, 毛东锋, 鱼玲玲, 刘文慧. 轻型β-地中海贫血供者异基因造血干细胞移植治疗重型再生障碍性贫血1例[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 84-86.
[11]	符莞孟, 王晓黎, 刘玉, 张潍, 张菊. 干细胞治疗多囊卵巢综合征的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 108-114.
[12]	任丽, 吴锡骅, 刘婷, 梅益彰. 沉默LncRNA MEG3调控miR-424-5p/FoxO1对氧化型低密度脂蛋白诱导的动脉粥样硬化的保护机制[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(06): 335-345.
[13]	陈彤, 张帆, 房橙橙, 李全海, 闫宝勇, 张君. 间充质干细胞与巨噬细胞相互作用机制的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(06): 372-377.
[14]	苏春艳, 吴涛, 毛东锋, 刘文慧, 鱼玲玲, 白海. 异基因造血干细胞移植治疗急性混合细胞白血病后继发外周T细胞淋巴瘤1例[J]. 中华细胞与干细胞杂志(电子版), 2022, 12(05): 289-292.
[15]	赵洁, 王岚, 杨红枚, 何屹, 袁红. 异基因造血干细胞移植后并发自身免疫性溶血性贫血患者产生类抗体血清学检测方法及输血策略[J]. 中华临床医师杂志(电子版), 2022, 16(05): 452-456.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Influence of hematopoietic stem cells induced from iPS cells on endothelial cell angiogenesis and related mechanisms

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Influence of hematopoietic stem cells induced from iPS cells on endothelial cell angiogenesis and related mechanisms